O
Owen Obel
Researcher at University of Texas Southwestern Medical Center
Publications - 29
Citations - 1694
Owen Obel is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Atrial fibrillation & Stent. The author has an hindex of 14, co-authored 29 publications receiving 1538 citations. Previous affiliations of Owen Obel include University of Texas at Dallas & St George's Hospital.
Papers
More filters
Journal ArticleDOI
Left atrial appendage: structure, function, and role in thromboembolism
N. Al-Saady,Owen Obel,A J Camm +2 more
TL;DR: The left atrial appendage (LAA) is derived from the left wall of the primary atrium, which forms during the fourth week of embryonic development and has developmental, ultrastructural, and physiological characteristics distinct from theleft atrium proper.
Journal ArticleDOI
A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial.
Emmanouil S. Brilakis,Christopher Lichtenwalter,Christopher Lichtenwalter,James A. de Lemos,Michele Roesle,Owen Obel,Donald Haagen,Bilal Saeed,Chiranjeevi Gadiparthi,Chiranjeevi Gadiparthi,Joe K. Bissett,Rajesh Sachdeva,Vassilios V. Voudris,Panagiotis Karyofillis,Biswajit Kar,James D. Rossen,Panayotis Fasseas,Peter B. Berger,Subhash Banerjee +18 more
TL;DR: In saphenous vein graft (SVG) lesions, PES are associated with lower rates of angiographic restenosis and target vessel failure than BMS.
Journal ArticleDOI
Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion
Mark M Gallagher,Brian J Hennessy,Nils Edvardsson,Ceara M Hart,Muriel S Shannon,Owen Obel,N. Al-Saady,A. John Camm +7 more
TL;DR: Cardioversion of atrial flutter presents similar risks and requires similar anticoagulation and should be performed within two days of the apparent onset of the arrhythmia if the duration of AF is uncertain or >2 days.
Journal ArticleDOI
A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure
Alan H. Kadish,Koonlawee Nademanee,Kent J. Volosin,Steven K. Krueger,Suresh Neelagaru,Nirav Raval,Owen Obel,Stanislav Weiner,Marc Wish,Peter E. Carson,Kenneth A. Ellenbogen,Robert C. Bourge,Michael K. Parides,Richard P. Chiacchierini,Rochelle L. Goldsmith,Sidney Goldstein,Yuval Mika,Daniel Burkhoff,William T. Abraham +18 more
TL;DR: In this paper, Cardiac contractility modulation (CCM) was used to deliver nonexcitatory electrical signals to the heart during the absolute refractory period intended to improve contraction.
Journal ArticleDOI
Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
William T. Abraham,Koonlawee Nademanee,Kent J. Volosin,Steven K. Krueger,Suresh Neelagaru,Nirav Raval,Owen Obel,Stanislav Weiner,Marc Wish,Peter E. Carson,Kenneth A. Ellenbogen,Robert C. Bourge,Michael K. Parides,Richard P. Chiacchierini,Rochelle L. Goldsmith,Sidney Goldstein,Yuval Mika,Daniel Burkhoff,Alan H. Kadish +18 more
TL;DR: In this paper, the authors evaluated the effect of CCM on ventilatory anaerobic threshold (VAT) in 428 NYHA functional class III/IV heart failure patients with narrow QRS.